Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals in 2025, more than half (26) were designated as rare disease (orphan) ...

Rather than relying on technological novelty, emerging biotechs must leverage strategic content and marketing intelligence to ...

Purdue’s strategic initiatives, which include leveraging the university’s extensive technological and computational environment and tackling complex challenges at the intersection of human, animal and ...

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...

Institutional investors face complex decisions—where to allocate capital, which managers to trust, how to weather volatility. These choices can’t rely on instinct alone. They require data, structure, ...

Explore the concept of real options, valuation methods, and practical examples. Learn how real options can influence company ...

Five steps to ensure that you don’t jump to solutions by Julia Binder and Michael D. Watkins When business leaders confront complex problems, there’s a powerful impulse to dive right into “solving” ...

Shelby is an editor with an affinity for covering home improvement and repair, design and real estate trends. She also specializes in content strategy and entrepreneur coaching for small businesses, ...